Microsporum audouinii tinea capitis in a Swiss school: Assessment and management of patients and asymptomatic carriers

Medical Mycology

Volumn 49, Issue 3, 2011, Pages 324-328

  Donghi, Davide ^a   Hauser, Valérie ^a   Bosshard, Philipp P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

anthropophilic dermatophytes; asymptomatic carriers; griseofulvin; Microsporum audouinii; tinea capitis

Indexed keywords

CICLOPIROX; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; PETROLATUM; POVIDONE IODINE; SALICYLIC ACID; SALICYLVASELINE; TERBINAFINE; UNCLASSIFIED DRUG;

ALOPECIA; ARTICLE; ASYMPTOMATIC INFECTION; CASE REPORT; CHILD; DISEASE CARRIER; DRUG DOSE INCREASE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECTOTHRIX; FAMILY ASSESSMENT; FUNGUS CULTURE; FUNGUS HYPHAE; FUNGUS TRANSMISSION; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIMARY SCHOOL; RECURRENT DISEASE; REINFECTION; SCHOOL CHILD; SCREENING TEST; SKIN DEFECT; SWITZERLAND; TINEA CAPITIS; TREATMENT RESPONSE;

ANTIFUNGAL AGENTS; CARRIER STATE; CHILD; HUMANS; MALE; MICROSPORUM; SCHOOLS; SWITZERLAND; TINEA CAPITIS; TREATMENT OUTCOME;

ARTHRODERMATACEAE; MICROSPORUM; MICROSPORUM AUDOUINII;

EID: 79952668382     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.522602     Document Type: Article

References (23)

1. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses 2007; 50(Suppl. 2): 6-13. (Pubitemid 47228556)
2. Panasiti V, Devirgiliis V, Borroni RG, et al. Epidemiology of der-matophytic infections in Rome, Italy: a retrospective study from 2002 to 2004. Med Mycol 2007; 45: 57-60. (Pubitemid 46992919)
3. Rezusta A, Betran A, Querol I, Palacian MP, Revillo MJ. Tinea capi-tis caused by Trichophyton soudanense and Microsporum audouinii in an adult: a case report. Mycoses 2009.
4. Roque HD, Vieira R, Rato S, Luz-Martins M. Specif c primers for rapid detection of Microsporum audouinii by PCR in clinical samples. J Clin Microbiol 2006; 44: 4336-4341. (Pubitemid 44937060)
5. Gräser Y, Kuijpers AF, El Fari M, Presber W, de Hoog GS. Molecular and conventional taxonomy of the Microsporum canis complex. Med Mycol 2000; 38: 143-153. (Pubitemid 30223730)
6. Akbaba M, Ilkit M, Sutoluk Z, Ates A, Zorba H. Comparison of hair-brush, toothbrush and cotton swab methods for diagnosing asympto-matic dermatophyte scalp carriage. J Eur Acad Dermatol Venereol 2008; 22: 356-362. (Pubitemid 351247428)
7. Ilkit M, Demirhindi H. Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management. Mycopatholo-gia 2008; 165: 61-71.
8. Brasch J, Hügel R, Lipowsky F, Gräser Y. Tinea corporis caused by an unusual strain of Microsporum audouinii that perforates hair in vitro. Mycoses 2010; 53: 360-362.
9. Kakourou T, Uksal U. Guidelines for the management of tinea capitis in children. Pediatr Dermatol 2010; 27: 226-228.
10. Gonzalez U, Seaton T, Bergus G, Jacobson J, Martinez-Monzon C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev 2007.
11. Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treat-ment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol 2004; 21: 499-502. (Pubitemid 39050631)
12. Gupta AK, Ginter G. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol 2001; 18: 519-522. (Pubitemid 34111147)
13. Binder B, Richtig E, Weger W, Ginter-Hanselmayer G. Tinea capitis in early infancy treated with itraconazole: a pilot study. J Eur Acad Dermatol Venereol 2009; 23: 1161-1163.
14. Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinaf ne. J Am Acad Dermatol 1999; 41: 60-63. (Pubitemid 29336854)
15. Fuller LC, Smith CH, Cerio R, et al. A randomized comparison of 4 weeks of terbinaf ne vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001; 144: 321-327. (Pubitemid 32178813)
16. Elewski BE, Caceres HW, DeLeon L, et al. Terbinaf ne hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol 2008; 59: 41-54.
17. Ali S, Graham TA, Forgie SE. The assessment and management of tinea capitis in children. Pediatr Emerg Care 2007; 23: 662-665; quiz 666-668.
18. Al Sogair S, Hay RJ. Fungal infection in children: tinea capitis. Clin Dermatol 2000; 18: 679-685. (Pubitemid 32118161)
19. Viguie-Vallanet C, Savaglio N, Piat C, Tourte-Schaefer C. Epidemi-ology of Microsporum langeronii tinea capitis in the Paris suburban area. Results of 2 school and familial surveys. Ann Dermatol Venereol 1997; 124: 696-699. (Pubitemid 27488175)
20. Weill FX, Bernier V, Maleville J, et al. Outbreak of tinea capitis caused by Microsporum audouinii var. langeronii in a school in Bor-deaux, France. J Mycol Med 1999; 9: 52-56. (Pubitemid 29217480)
21. Haedersdal M, Stenderup J, Moller B, Agner T, Svejgaard EL. An out-break of tinea capitis in a child care centre. Dan Med Bull 2003; 50: 83-84. (Pubitemid 36285912)
22. McPherson ME, Woodgyer AJ, Simpson K, Chong AH. High preva-lence of tinea capitis in newly arrived migrants at an English-language school, Melbourne, 2005. Med J Aust 2008; 189: 13-16.
23. Ive FA. The carrier stage of tinea capitis in Nigeria. Br J Dermatol 1966; 78: 219-221.